Segmental bone defects: From cellular and molecular pathways to the development of novel biological treatments

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 11, 2010, Pages 2561-2569

  Pneumaticos, Spyros G ^a   Triantafyllopoulos, Georgios K ^a   Basdra, Efthimia K ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Bone defects; Growth factors; Scaffolds; Stem cells; Tissue engineering

Indexed keywords

ANIMAL; ARTICLE; BONE DISEASE; BONE REGENERATION; HUMAN; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BONE DISEASES; BONE REGENERATION; HUMANS; SIGNAL TRANSDUCTION;

EID: 77958536012     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01062.x     Document Type: Article

References (111)

1. Laurencin C, Khan Y, El-Amin SF. Bone graft substitutes. Expert Rev Med Devices. 2006; 3: 49-57.
2. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for cranio-mandibular non unions. Clin Orthop. 1986; 205: 299-308.
3. Gugala Z, Gogolewski S. Regeneration of segmental diaphyseal defects in sheep tibiae using resorbable polymeric membranes: a preliminary study. J Orthop Trauma. 1999; 13: 187-95.
4. Gugala Z, Lindsey RW, Gogolewski S. New approaches in the treatment of critical-size segmental defects in long bones. Macromol Symp. 2007; 253: 147-61.
5. Frost HM. Bone's mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol. 2003; 275: 1081-101.
6. Papachroni KK, Karatzas D, Papavassiliou KA, et al Mechanotransduction in osteoblast regulation and bone disease. Trends Mol Med. 2009; 15: 208-16.
7. Anderson DM, Maraskovsky E, Billingsley WL, et al A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 1997; 390: 175-9.
8. Lacey DL, Timms E, Tan HL, et al Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93: 165-76.
9. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003; 423: 337-42.
10. Blair HC, Athanasou NA. Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol. 2004; 14: 255-70.
11. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Therapy. 2008; 15: 109-16.
12. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med. 2008; 2: 1-13.
13. Janssens K, Ten Dijke P, Janssens S, et al Transforming growth factor-β1 to the bone. Endocr Rev. 2005; 26: 743-74.
14. Horner A, Kemp P, Summers C, et al Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone. 1998; 23: 95-102.
15. Opperman LA, Nolen AA, Ogle RC. TGF-βeta 1, TGF-βeta 2, and TGF-βeta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Miner Res. 1997; 12: 301-10.
16. Ripamonti U. Soluble osteogenic molecular signals and the induction of bone formation. Biomaterials. 2006; 27: 807-22.
17. McCarthy TL, Ji C, Centrella M. Links among growth factors, hormones, and nuclear factors with essential roles in bone formation. Crit Rev Oral Biol Med. 2000; 11: 409-22.
18. Koga T, Matsui Y, Asagiri M, et al NFAT and Osterix cooperatively regulate bone formation. Nat Med. 2005; 11: 880-5.
19. Winslow MM, Pan M, Starbuck M, et al Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell. 2006; 10: 771-82.
20. Wada T, Nakashima T, Hiroshi N, et al RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006; 12: 17-25.
21. Papachristou DJ, Papachroni KK, Basdra EK, et al Signaling networks and transcription factors regulating mechanotransduction in bone. BioEssays. 2009; 31: 794-804.
22. Scheufler O, Schaefer DJ, Jaquiery C, et al Spatial and temporal patterns of bone formation in ectopically pre-fabricated, autologous cell-based engineered bone flaps in rabbits. J Cell Mol Med. 2008; 12: 1238-49.
23. Perry CR. Bone repair techniques, bone graft, and bone graft substitutes. Clin Orthop. 1999; 360: 71-86.
24. Ceruso M, Falcone C, Innocenti M, et al Skeletal reconstruction with a free vascularized fibula graft associated to bone allograft after resection of malignant bone tumor of limbs. Handchir Mikrochir Plast Chir. 2001; 33: 277-82.
25. Moran SL, Shin AY, Bishop AT. The use of massive bone allograft with intramedullary free fibular flap for limb salvage in a pediatric and adolescent population. Plast Reconstr Surg. 2006; 118: 413-9.
26. Ilizarov GA. Clinical application of the tension-stress effect for limb lengthening. Clin Orthop Relat Res. 1990; 250: 8-26.
27. Ilizarov GA. The tension-stress effect on the genesis and growth of tissues: part I. The influence of stability of fixation and soft-tissue preservation. Clin Orthop Relat Res. 1989; 238: 249-81.
28. Ilizarov GA. The tension-stress effect on the genesis and growth of tissues: part II. The influence of the rate and frequency of distraction. Clin Orthop Relat Res. 1989; 239: 263-85.
29. Aronson J. Temporal and spatial increases in blood flow during distraction osteogenesis. Clin Orthop. 1994; 301: 124-31.
30. Mahendra A, Maclean AD. Available biological treatments for complex non-unions. Injury. 2007; 38: S7-12.
31. Lewandrowski KU, Venugopalan V, Tomford WW, et al Kinetics of cortical bone demineralization: controlled demineralization-a new method for modifying cortical bone allografts. J Biomed Mater Res. 1996; 31: 365-72.
32. Langer R, Vacanti JP. Tissue engineering. Science. 1993; 260: 920-6.
33. Stock UA, Vacanti JP. Tissue engineering: current state and prospects. Annu Rev Med. 2001; 52: 443-51.
34. Stevens B, Yang Y, Mohandas A, et al A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues. J Biomed Mater Res. 2008; 85B: 573-82.
35. Bruder SP, Neelam J, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biol. 1997; 64: 278-94.
36. Tsuchida H, Hashimoto J, Crawford E, et al Engineered allogenic mesenchymal stem cells repair femoral segmental defect in rats. J Orthop Research. 2003; 21: 44-53.
37. Bianco P, Robey PG. Stem cells in tissue engineering. Nature. 2001; 414: 118-21.
38. Friedenstein AJ, Deriglasova UF, Kulagina , et al Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974; 2: 83-92.
39. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991; 9: 641-50.
40. Pittenger MF, Mackey AM, Beck SC, et al Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7.
41. Bianco P, Kuznetsov SA, Riminucci M, et al Postnatal skeletal stem cells. In: Klimanskaya I, Lanza R, editors. Methods in enzymology, Volume 419. New York Academic Press; 2006. pp. 117-48.
42. Stenderup K, Justesen J, Clausen C, et al Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003; 33: 919-26.
43. Harley CB. Telomere loss: mitotic clock or genetic time bomb Mutat Res. 1991; 256: 271-82.
44. Burns JS, Abdallah BM, Guldberg P, et al Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res. 2005; 65: 3126-35.
45. Bianchi G, Banfi A, Mastrogiacomo M, et al Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor. Exp Cell Res. 2003; 287: 98-105.
46. Ducy P, Zhang R, Geoffroy V, et al Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997; 89: 747-54.
47. Rifas L. The role of noggin in human mesenchymal stem cell differentiation. J Cell Biochem. 2007; 100: 824-34.
48. Naldini L, Blomer U, Gallay P, et al In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996; 272: 263-7.
49. Chao W, Qiling H, Gang L. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model. J Orthop Res. 2006; 24: 610-8.
50. Ohgushi H, Goldberg VM, Caplan AI. Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop Scand. 1989; 60: 334-9.
51. Oedayrajsingh-Varma MJ, Van Ham SM, Knippenberg M, et al Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy. 2006; 8: 166-77.
52. Astori G, Vignati F, Bardelli S, et al "In vitro" and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal stem cells. J Transl Med. 2007; 5: 55.
53. Zuk PA, Zhu M, Ashjian P, et al Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13: 4279-95.
54. Aust L, Devlin B, Foster SJ, et al Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy. 2004; 6: 7-14.
55. Urist MR. Bone: formation by autoinduction. Science. 1965; 150: 893-9.
56. Urist MR, Mikulski A, Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA. 1979; 76: 1828-32.
57. Urist MR, Sato K, Brownell AG, et al Human bone morphogenetic protein (hBMP). Proc Soc Exp Biol Med. 1983; 173: 194-9.
58. Sampath TK, Reddi AH. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci USA. 1981; 78: 7599-603.
59. Reddi AH, Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci USA. 1972; 69: 1601-5.
60. Reddi AH. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng. 2000; 6: 351-9.
61. Wozney JM, Rosen V, Celeste AJ, et al Novel regulators of bone formation: molecular clones and activities. Science. 1988; 242: 1528-34.
62. Aono A, Hazama M, Notoya K, et al Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. Biochem Biophys Res Commun. 1995; 210: 670-7.
63. Heldin CH, Miyazono K, Ten Dijke P. TGFβ signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997; 390: 465-71.
64. Sebald W, Nickel J, Zhang JL, et al Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol Chem. 2004; 385: 697-710.
65. Miyazono K, Maeda S, Imamura T. Coordinate regulation of cell growth and differentiation by TGFβ superfamily and Runx proteins. Oncogene. 2004; 23: 4232-7.
66. Derynck R, Zhang YE. Smad-dependent and Smad independent pathways in TGFβ family signalling. Nature. 2003; 425: 577-84.
67. Celil AB, Hollinger JO, Campbell PG. Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem. 2005; 95: 518-28.
68. Sowa H, Kaji H, Hendy GN, et al Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2. J Biol Chem. 2004; 279: 40267-75.
69. Maeda S, Hayashi M, Komiya S, et al Endogenous TGFβ signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J. 2004; 23: 552-63.
70. Cook SD, Baffes GC, Wolfe MW, et al Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop. 1994; 301: 302-12.
71. Cook SD, Baffes GC, Wolfe MW, et al The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am. 1994; 76: 827-8.
72. Chen X, Kidder LS, Lew WD. Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur. J Orthop Res. 2002; 20: 142-50.
73. Geesink RG, Hoefnagels NH, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br. 1999; 81: 710-8.
74. Jones AL, Bucholz RW, Bosse MJ, et al Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am. 2006; 88: 1431-41.
75. Riedel GE, Valentin-Opran A. Clinical evaluation of rh-BMP-2/ ACS in orthopedic trauma: a progress report. Orthopedics. 1999; 22: 663-5.
76. BESTT Study Group. Recombinant human bone morphogenic protein-2 for the treatment of open tibial fractures: a prospective, controlled randomised study of four hundred and fifty patients. J Bone Joint Surg Am. 2002; 84: 2123-34.
77. Swiontkowski MF, Aro HT, Donell S, et al Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am. 2006; 88: 1258-65.
78. th Annual Meeting of the Orthopaedic Trauma Association. Toronto, Ontario, Canada; October 11-13; 2002. pp. 157-58.
79. Saito A, Suzuki Y, Ogata S, et al Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide. J Biomed Mater Res. 2004; 70: 115-21.
80. Shinar DM, Endo N, Halperin D, et al Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone. Endocrinology. 1993; 132: 1158-67.
81. Canalis E. Insulin-like growth factors and the local regulation of bone formation. Bone. 1993; 14: 273-6.
82. Mochizuki H, Hakeda Y, Wakatsuki N, et al Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology. 1992; 131: 1075-80.
83. Flanagan AM, Chambers TJ. Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2. Endocrinology. 1992; 130: 443-8.
84. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999; 79: 1193-226.
85. Weinreb M, Grosskopf A, Shir N. The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype. Am J Physiol. 1999; 276: E376-83.
86. Senkoylu A, Uzunok D, Piskin E. Treatment of segmental bone defects in rats by the stimulation of bone marrow osteo-progenitor cells with prostaglandin E2. Int Orthop. 2005; 29: 73-7.
87. Wu D, Razzano P, Grande DA. Gene therapy and tissue engineering in repair of the musculoskeletal system. J Cell Biochem. 2003; 88: 467-81.
88. Chang SC, Chuang H, Chen YR, et al Cranial repair using BMP-2 gene engineered bone marrow stromal cells. J Surg Res. 2004; 119: 85-91.
89. Bonadio J, Smiley E, Patil P, et al Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med. 1999; 5: 753-9.
90. Kneser U, Schaefer DJ, Polykandriotis E, et al Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med. 2006; 10: 7-19.
91. Navarro M, Michiardi A, Castaño O, et al Biomaterials in orthopaedics. J R Soc Interface. 2008; 5: 1137-58.
92. Ducheyne P, Qiu Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials. 1999; 20: 2287-303.
93. Ciccone W, Motz C, Bentley C, et al Bioabsorbable implants in orthopaedics: new developments and clinical applications. J Am Acad Orthop Surg. 2001; 9: 280-8.
94. Brady JM, Cutright DE, Miller RA, et al Resorption rate, route of elimination, and ultrastructure of implant site of polylactic acid in abdominal-wall of rat. J Biomed Mater Res. 1973; 7: 155-66.
95. Kasuga T, Maeda H, Kato K, et al Preparation of poly(lactic acid) composites containing calcium carbonate (vaterite). Biomaterials. 2003; 24: 3247-53.
96. Kunze C, Freier T, Heldwig E, et al Surface modification of tricalcium phosphate for improvement of the interfacial compatibility with biodegradable polymers. Biomaterials. 2003; 24: 967-74.
97. Boccaccini AR, Roether JA, Hench LL, et al A composites approach to tissue engineering. Ceram Eng Sci Proc. 2002; 23: 805-16.
98. Hutmacher DW, Schantz JT, Lam CXF, et al State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med. 2007; 1: 245-60.
99. Habibovic P, De Groot K. Osteoinductive biomaterials - properties and relevance in bone repair. J Tissue Eng Regen Med. 2007; 1: 25-32.
100. Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials. 1996; 17: 31-5.
101. Klawitter JJ, Hulbert SF. Application of porous ceramics for the attachment of load-bearing internal orthopedic applications. Cell Transplant. 1971; 3: 339.
102. Babis GC, Soucacos PN. Bone scaffolds: the role of mechanical stability and instrumentation. Injury. 2005; 36S: S38-44.
103. Trojani C, Boukhechba F, Scimeca JC, et al Ectopic bone formation using an injectable biphasic calcium phosphate/Si-HPMC hydrogel composite loaded with undifferentiated bone marrow stromal cells. Biomaterials. 2006; 27: 3256-64.
104. Folkman J, Hochberg M. Self-regulation of growth in three dimensions. J Exp Med. 1973; 138: 745-53.
105. Koike N, Fukumura D, Gralla O, et al Tissue engineering: creation of long-lasting blood vessels. Nature. 2004; 428: 138-9.
106. Geiger F, Bertram H, Berger I, et al Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res. 2005; 20: 2028-35.
107. Peng H, Usas A, Olshanski A, et al VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res. 2005; 20: 2017-27.
108. Khouri RK, Koudsi B, Reddi H. Tissue transformation into bone in vivo. A potential practical application. JAMA. 1991; 266: 1953-5.
109. Warnke PH, Springer ING, Wiltfang J, et al Growth transplantation of a custom vascularized bone graft in a man. Lancet. 2004; 364: 766-70.
110. Heliotis M, Lavery KM, Ripamonti U, et al Transformation of a prefabricated hydroxyapatite/osteogenic protein-1 implant into a vascularized pedicled bone flap in the human chest. Int J Oral Macillofac Surg. 2006; 35: 265-9.
111. Jiang F, Zhang G, Hashimoto I, et al Neovascularization in an arterio-venous loop-containing tissue engineering chamber: role of NADPH oxidase. J Cell Mol Med. 2008; 12: 2062-72.